For the roughly 64,000 Americans diagnosed with pancreatic cancer each year, the prognosis remains grim — though regimens ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

A homegrown Northwestern drug is giving Chicago-area families something they almost never get with metastatic pancreatic ...

Elraglusib plus chemotherapy doubled one-year survival in metastatic pancreatic cancer, showing improved outcomes in a phase ...

New experimental medications seem to extend survival with the hard-to-treat cancer.

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Bill Salter, senior director of radiation oncology at the Huntsman Cancer Institute, gives a tour of the treatment room at the ...

For patients with metastatic pancreatic cancer, new treatment options are urgently needed to increase survival time and ...

BUFFALO, N.Y. — Roswell Park Comprehensive Cancer Center is celebrating a new report with positive news about cancer survivorship rates. In the annual report from the American Cancer Society tracking ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

No matter which side of the political spectrum you sit on, good news can feel hard to come by these days — which is why the most recent annual report from the American Cancer Society is such a boon.

All women should discuss cancer screenings with their own doctor.

Asian American women with breast cancer had higher survival rates than white women, though outcomes differed across ethnic ...